Thank you @RepThomasMassie for the opportunity to explain to members of Congress how C19 vaccine trials compare to childhood vaccine trials and to drug trials, and why the differential. Potential liability incentivizes safety. Remove that threat, you get dangerous products. pic.twitter.com/2t7Q79zoHQ
— Aaron Siri (@AaronSiriSG) July 29, 2024
Monday, July 29, 2024
Potential liability incentivizes safety. Remove that threat, you get dangerous products.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment